Comparison of 1% Versus 2% Lignocaine for Topical Anaesthesia in Endobronchial Ultrasound Guided Transbronchial Needle Aspiration
Sponsor study identifier
interventional
100
1 country
1
Study Start
May 2016
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
June 2017
Actual (reported)Study Completion
June 2017
Actual (reported)Endobronchial Ultrasound Guided Transbronchial Needle Aspiration (EBUS -TBNA) is commonly performed for diagnosis of mediastinal pathologies. The procedure can either be performed under general anaesthesia or under moderate sedation with topical anaesthesia. Most patients tolerate the procedure well although cough is often reported as a distressing symptom. Topical lignocaine is administered during bronchoscopy for local anaesthesia. There is no literature on the efficacy of lower concentrations (1%) versus a higher (2%) during EBUS TBNA. This study would help to determine whether 1% lignocaine is as effective as 2% lignocaine for airway anaesthesia during EBUS-TBNA.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2017
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 2016
Date type not reportedThis date has not been verified as actual or estimated.
September 21, 2016
Actual (reported)September 23, 2016
Actual (reported)June 2017
Actual (reported)June 2017
Actual (reported)Operator rated cough VAS
At study completion approximately 6 months
Operator rated overall procedure satisfaction VAS
At study completion approximately 6 months
Total lignocaine dose administered
At study completion approximately 6 months
Patient facies pain rating scale
At study completion approximately 6 months
Procedure related adverse events
At study completion approximately 6 months
1 % Lignocaine administered for topical anaesthesia during EBUS-TBNA
2 % Lignocaine administered for topical anaesthesia during EBUS-TBNA
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
All India Institute of Medical Sciences
New Delhi, 110029, India
Randeep Guleria, MD, DM
All India Institute of Medical Sciences
100 participants (actual enrollment reported by the registry).
First Submitted
September 21, 2016
First Posted
September 23, 2016
Study Start
May 2016
Date type not reportedContact the study team to confirm eligibility.
This date has not been verified as actual or estimated.
Primary Completion
June 2017
Actual (reported)Study Completion
June 2017
Actual (reported)Last Updated
August 22, 2017
Record last verified: 2017-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: